Assessing Patient Confidence With Biosimilars

From respiratory conditions to rare diseases and beyond, here are 5 groundbreaking FDA approvals from last month.

Bone density was found to be lower in those diagnosed with HIV vs those who were HIV-negative.

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

The use of cemiplimab with chemotherapy showed durable improvements in survival outcomes for non-small cell lung cancer (NSCLC) after 5 years.

AD-related outcomes were compared in patients treated with JAK1 inhibitors and IL-13 antibodies, with short-term efficacy biomarkers considered for treatment outcomes.